{{PBB|geneid=5371}}
'''早幼粒细胞白血病蛋白'''是指可能的转录因子可能的转录因子（{{lang-en|'''Probable transcription factor PML'''}}），是一个由人类[[基因|基因]] ''PML'' 编码的抑癌蛋白。

== 功能 ==
== 互作 ==

早幼粒细胞白血病蛋白可与下列蛋白質发生[[蛋白質交互作用|交互作用]]：
{{div col|colwidth=20em}}
* [[ANKRD2|ANKRD2]],<ref name = pmid15136035>{{Cite journal|last=Kojic|first=Snezana|last2=Medeot|first2=Elisa|last3=Guccione|first3=Ernesto|last4=Krmac|first4=Helena|last5=Zara|first5=Ivano|last6=Martinelli|first6=Valentina|last7=Valle|first7=Giorgio|last8=Faulkner|first8=Georgine|date=2004-05|title=The Ankrd2 Protein, a Link Between the Sarcomere and the Nucleus in Skeletal Muscle|url=https://linkinghub.elsevier.com/retrieve/pii/S0022283604003894|journal=Journal of Molecular Biology|language=en|volume=339|issue=2|doi=10.1016/j.jmb.2004.03.071|access-date=2022-06-16|archive-date=2022-06-15|archive-url=https://web.archive.org/web/20220615194818/https://linkinghub.elsevier.com/retrieve/pii/S0022283604003894}}</ref>
* [[CREB-binding_protein|CREB-binding protein]],<ref name = pmid10610177/><ref name = pmid12622724>{{Cite journal|last=Matsuzaki|first=Kazuhito|last2=Minami|first2=Takeshi|last3=Tojo|first3=Masahide|last4=Honda|first4=Yoshiomi|last5=Saitoh|first5=Noriko|last6=Nagahiro|first6=Shinji|last7=Saya|first7=Hideyuki|last8=Nakao|first8=Mitsuyoshi|date=2003-03|title=PML-nuclear bodies are involved in cellular serum response|url=https://pubmed.ncbi.nlm.nih.gov/12622724|journal=Genes to Cells: Devoted to Molecular & Cellular Mechanisms|volume=8|issue=3|doi=10.1046/j.1365-2443.2003.00632.x|issn=1356-9597|pmid=12622724|access-date=2022-06-16|archive-date=2022-06-16|archive-url=https://web.archive.org/web/20220616064548/https://pubmed.ncbi.nlm.nih.gov/12622724/}}</ref><ref name = pmid10077561>{{Cite journal|last=Doucas|first=Vassilis|last2=Tini|first2=Marc|last3=Egan|first3=David A.|last4=Evans|first4=Ronald M.|date=1999-03-16|title=Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling|url=https://pnas.org/doi/full/10.1073/pnas.96.6.2627|journal=Proceedings of the National Academy of Sciences|language=en|volume=96|issue=6|doi=10.1073/pnas.96.6.2627|issn=0027-8424|pmc=PMC15819|pmid=10077561|access-date=2022-06-16|archive-date=2022-06-16|archive-url=https://web.archive.org/web/20220616064546/https://www.pnas.org/doi/full/10.1073/pnas.96.6.2627}}</ref>
* [[Cyclin_T1|Cyclin T1]],<ref name = pmid12727882>{{Cite journal|last=Marcello|first=A.|date=2003-05-01|title=Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein|url=http://emboj.embopress.org/cgi/doi/10.1093/emboj/cdg205|journal=The EMBO Journal|volume=22|issue=9|doi=10.1093/emboj/cdg205|pmc=PMC156077|pmid=12727882}}</ref>
* [[Death_associated_protein_6|Death associated protein 6]],<ref name = pmid10525530>{{Cite journal|last=Ishov|first=Alexander M.|last2=Sotnikov|first2=Alexey G.|last3=Negorev|first3=Dmitri|last4=Vladimirova|first4=Olga V.|last5=Neff|first5=Norma|last6=Kamitani|first6=Tetsu|last7=Yeh|first7=Edward T.H.|last8=Strauss|first8=Jerome F.|last9=Maul|first9=Gerd G.|date=1999-10-18|title=Pml Is Critical for Nd10 Formation and Recruits the Pml-Interacting Protein Daxx to This Nuclear Structure When Modified by Sumo-1|url=https://rupress.org/jcb/article/147/2/221/20075/Pml-Is-Critical-for-Nd10-Formation-and-Recruits|journal=Journal of Cell Biology|language=en|volume=147|issue=2|doi=10.1083/jcb.147.2.221|issn=0021-9525|pmc=PMC2174231|pmid=10525530|access-date=2022-06-16|archive-date=2022-06-16|archive-url=https://web.archive.org/web/20220616064549/https://rupress.org/jcb/article/147/2/221/20075/Pml-Is-Critical-for-Nd10-Formation-and-Recruits}}</ref><ref name = pmid10669754>{{Cite journal|last=Li|first=Hui|last2=Leo|first2=Christopher|last3=Zhu|first3=Jiang|last4=Wu|first4=Xiaoyang|last5=O'Neil|first5=Jennifer|last6=Park|first6=Eun-Ju|last7=Chen|first7=J. Don|date=2000-03|title=Sequestration and Inhibition of Daxx-Mediated Transcriptional Repression by PML|url=https://journals.asm.org/doi/10.1128/MCB.20.5.1784-1796.2000|journal=Molecular and Cellular Biology|language=en|volume=20|issue=5|doi=10.1128/MCB.20.5.1784-1796.2000|issn=0270-7306|pmc=PMC85360|pmid=10669754|access-date=2022-06-16|archive-date=2021-11-28|archive-url=https://web.archive.org/web/20211128141331/https://journals.asm.org/doi/10.1128/MCB.20.5.1784-1796.2000}}</ref><ref name = pmid11244500>{{Cite journal|last=Lehembre|first=François|last2=Müller|first2=Stefan|last3=Pandolfi|first3=Pier Paolo|last4=Dejean|first4=Anne|date=2001-01-04|title=Regulation of Pax3 transcriptional activity by SUMO-1-modified PML|url=https://www.nature.com/articles/1204063|journal=Oncogene|language=en|volume=20|issue=1|doi=10.1038/sj.onc.1204063|issn=0950-9232|pmid=11244500|access-date=2022-06-16|archive-date=2021-08-11|archive-url=https://web.archive.org/web/20210811014817/https://www.nature.com/articles/1204063}}</ref><ref name = pmid10684855>{{Cite journal|last=Zhong|first=Sue|last2=Salomoni|first2=Paolo|last3=Ronchetti|first3=Simona|last4=Guo|first4=Ailan|last5=Ruggero|first5=Davide|last6=Pandolfi|first6=Pier Paolo|date=2000-02-21|title=Promyelocytic Leukemia Protein (Pml) and Daxx Participate in a Novel Nuclear Pathway for Apoptosis|url=https://rupress.org/jem/article/191/4/631/30048/Promyelocytic-Leukemia-Protein-Pml-and-Daxx|journal=Journal of Experimental Medicine|language=en|volume=191|issue=4|doi=10.1084/jem.191.4.631|issn=0022-1007|pmc=PMC2195846|pmid=10684855|access-date=2022-06-16|archive-date=2022-06-16|archive-url=https://web.archive.org/web/20220616064552/https://rupress.org/jem/article/191/4/631/30048/Promyelocytic-Leukemia-Protein-Pml-and-Daxx}}</ref>
* [[GATA2|GATA2]],<ref name = pmid10938104>{{Cite journal|last=Tsuzuki|first=Shinobu|last2=Towatari|first2=Masayuki|last3=Saito|first3=Hidehiko|last4=Enver|first4=Tariq|date=2000-09|title=Potentiation of GATA-2 Activity through Interactions with the Promyelocytic Leukemia Protein (PML) and the t(15;17)-Generated PML-Retinoic Acid Receptor α Oncoprotein|url=https://journals.asm.org/doi/10.1128/MCB.20.17.6276-6286.2000|journal=Molecular and Cellular Biology|language=en|volume=20|issue=17|doi=10.1128/MCB.20.17.6276-6286.2000|issn=0270-7306|pmc=PMC86102|pmid=10938104|access-date=2022-06-16|archive-date=2022-06-16|archive-url=https://web.archive.org/web/20220616063924/https://journals.asm.org/doi/10.1128/MCB.20.17.6276-6286.2000}}</ref>
* [[HDAC1|HDAC1]],<ref name = pmid11430826>{{Cite journal|last=Khan|first=M. M.|last2=Nomura|first2=T.|last3=Kim|first3=H.|last4=Kaul|first4=S. C.|last5=Wadhwa|first5=R.|last6=Shinagawa|first6=T.|last7=Ichikawa-Iwata|first7=E.|last8=Zhong|first8=S.|last9=Pandolfi|first9=P. P.|last10=Ishii|first10=S.|date=2001-06|title=Role of PML and PML-RARalpha in Mad-mediated transcriptional repression|url=https://pubmed.ncbi.nlm.nih.gov/11430826|journal=Molecular Cell|volume=7|issue=6|doi=10.1016/s1097-2765(01)00257-x|issn=1097-2765|pmid=11430826|access-date=2022-06-16|archive-date=2021-11-28|archive-url=https://web.archive.org/web/20211128140856/https://pubmed.ncbi.nlm.nih.gov/11430826/}}</ref><ref name = pmid11259576>{{Cite journal|last=Wu|first=Wen-Shu|last2=Vallian|first2=Sadeq|last3=Seto|first3=Edward|last4=Yang|first4=Wen-Ming|last5=Edmondson|first5=Diane|last6=Roth|first6=Sharon|last7=Chang|first7=Kun-Sang|date=2001-04|title=The Growth Suppressor PML Represses Transcription by Functionally and Physically Interacting with Histone Deacetylases|url=https://journals.asm.org/doi/10.1128/MCB.21.7.2259-2268.2001|journal=Molecular and Cellular Biology|language=en|volume=21|issue=7|doi=10.1128/MCB.21.7.2259-2268.2001|issn=0270-7306|pmc=PMC86860|pmid=11259576|access-date=2022-06-16|archive-date=2022-06-16|archive-url=https://web.archive.org/web/20220616063916/https://journals.asm.org/doi/10.1128/MCB.21.7.2259-2268.2001}}</ref>
* [[HDAC3|HDAC3]],<ref name = pmid11259576/>
* [[HHEX|HHEX]],<ref name = pmid10597310>{{Cite journal|last=Topcu|first=Zeki|last2=Mack|first2=David L|last3=Hromas|first3=Robert A|last4=Borden|first4=Katherine LB|date=1999-11-25|title=The promyelocytic leukemia protein PML interacts with the proline-rich homeodomain protein PRH: a RING may link hematopoiesis and growth control|url=https://www.nature.com/articles/1203201|journal=Oncogene|language=en|volume=18|issue=50|doi=10.1038/sj.onc.1203201|issn=0950-9232|pmid=10597310|access-date=2022-06-16|archive-date=2022-06-16|archive-url=https://web.archive.org/web/20220616064550/https://www.nature.com/articles/1203201}}</ref>
* [[MAPK11|MAPK11]],<ref name = pmid15273249>{{Cite journal|last=Shin|first=Jinwook|last2=Park|first2=Boyoun|last3=Cho|first3=Sunglim|last4=Lee|first4=Sunray|last5=Kim|first5=Youngkyun|last6=Lee|first6=Seong-Ok|last7=Cho|first7=Kwangmin|last8=Lee|first8=Sungwook|last9=Jin|first9=Bong-Suk|last10=Ahn|first10=Jin-Hyun|last11=Choi|first11=Eui-Ju|date=2004-09-24|title=Promyelocytic leukemia is a direct inhibitor of SAPK2/p38 mitogen-activated protein kinase|url=https://pubmed.ncbi.nlm.nih.gov/15273249|journal=The Journal of Biological Chemistry|volume=279|issue=39|doi=10.1074/jbc.M407369200|issn=0021-9258|pmid=15273249|access-date=2022-06-16|archive-date=2022-06-16|archive-url=https://web.archive.org/web/20220616063921/https://pubmed.ncbi.nlm.nih.gov/15273249/}}</ref>
* [[MYB|MYB]],<ref name = pmid15194430>{{Cite journal|last=Dahle|first=Øyvind|last2=Bakke|first2=Oddmund|last3=Gabrielsen|first3=Odd Stokke|date=2004-07-01|title=c-Myb associates with PML in nuclear bodies in hematopoietic cells|url=https://pubmed.ncbi.nlm.nih.gov/15194430|journal=Experimental Cell Research|volume=297|issue=1|doi=10.1016/j.yexcr.2004.03.014|issn=0014-4827|pmid=15194430|access-date=2022-06-16|archive-date=2022-06-16|archive-url=https://web.archive.org/web/20220616063921/https://pubmed.ncbi.nlm.nih.gov/15194430/}}</ref>
* [[Mdm2|Mdm2]],<ref name = pmid12915590/><ref name = pmid15195100/><ref name = pmid14507915>{{Cite journal|last=Zhu|first=Hongyan|last2=Wu|first2=Liqing|last3=Maki|first3=Carl G.|date=2003-12-05|title=MDM2 and promyelocytic leukemia antagonize each other through their direct interaction with p53|url=https://pubmed.ncbi.nlm.nih.gov/14507915|journal=The Journal of Biological Chemistry|volume=278|issue=49|doi=10.1074/jbc.M308302200|issn=0021-9258|pmid=14507915|access-date=2022-06-16|archive-date=2022-06-16|archive-url=https://web.archive.org/web/20220616064546/https://pubmed.ncbi.nlm.nih.gov/14507915/}}</ref><ref name = pmid12759344>{{Cite journal|last=Wei|first=Xiaolong|last2=Yu|first2=Zhong Kang|last3=Ramalingam|first3=Arivudainambi|last4=Grossman|first4=Steven R.|last5=Yu|first5=Jiang H.|last6=Bloch|first6=Donald B.|last7=Maki|first7=Carl G.|date=2003-08-01|title=Physical and functional interactions between PML and MDM2|url=https://pubmed.ncbi.nlm.nih.gov/12759344|journal=The Journal of Biological Chemistry|volume=278|issue=31|doi=10.1074/jbc.M212215200|issn=0021-9258|pmid=12759344|access-date=2022-06-16|archive-date=2022-06-16|archive-url=https://web.archive.org/web/20220616063922/https://pubmed.ncbi.nlm.nih.gov/12759344/}}</ref>
* [[Nerve_Growth_factor_IB|Nerve Growth factor IB]],<ref name = pmid12032831>{{Cite journal|last=Wu|first=Wen-Shu|last2=Xu|first2=Zhi-Xiang|last3=Ran|first3=Ruixiang|last4=Meng|first4=Feng|last5=Chang|first5=Kun-Sang|date=2002-05-30|title=Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactions|url=https://www.nature.com/articles/1205491|journal=Oncogene|language=en|volume=21|issue=24|doi=10.1038/sj.onc.1205491|issn=0950-9232|pmid=12032831|access-date=2022-06-16|archive-date=2022-06-16|archive-url=https://web.archive.org/web/20220616064555/https://www.nature.com/articles/1205491}}</ref>
* [[Nuclear_receptor_co-repressor_1|Nuclear receptor co-repressor 1]],<ref name = pmid11430826/>
* [[Nuclear_receptor_co-repressor_2|Nuclear receptor co-repressor 2]],<ref name = pmid11430826/><ref name = pmid11585900>{{Cite journal|last=Hong|first=Suk-Hyun|last2=Yang|first2=Zhihong|last3=Privalsky|first3=Martin L.|date=2001-11|title=Arsenic Trioxide Is a Potent Inhibitor of the Interaction of SMRT Corepressor with Its Transcription Factor Partners, Including the PML-Retinoic Acid Receptor α Oncoprotein Found in Human Acute Promyelocytic Leukemia|url=https://journals.asm.org/doi/10.1128/MCB.21.21.7172-7182.2001|journal=Molecular and Cellular Biology|language=en|volume=21|issue=21|doi=10.1128/MCB.21.21.7172-7182.2001|issn=0270-7306|pmc=PMC99892|pmid=11585900|access-date=2022-06-16|archive-date=2021-08-11|archive-url=https://web.archive.org/web/20210811014743/https://journals.asm.org/doi/10.1128/MCB.21.21.7172-7182.2001}}</ref>
* [[P53|P53]],<ref name = pmid12915590>{{Cite journal|last=Kurki|first=Sari|last2=Latonen|first2=Leena|last3=Laiho|first3=Marikki|date=2003-10-01|title=Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization|url=https://journals.biologists.com/jcs/article/116/19/3917/35085/Cellular-stress-and-DNA-damage-invoke-temporally|journal=Journal of Cell Science|language=en|volume=116|issue=19|doi=10.1242/jcs.00714|issn=1477-9137|pmid=12915590|access-date=2022-06-16|archive-date=2022-06-16|archive-url=https://web.archive.org/web/20220616051652/https://journals.biologists.com/jcs/article/116/19/3917/35085/Cellular-stress-and-DNA-damage-invoke-temporally}}</ref><ref name = pmid11080164>{{Cite journal|last=Fogal|first=V.|date=2000-11-15|title=Regulation of p53 activity in nuclear bodies by a specific PML isoform|url=http://emboj.embopress.org/cgi/doi/10.1093/emboj/19.22.6185|journal=The EMBO Journal|volume=19|issue=22|doi=10.1093/emboj/19.22.6185|pmc=PMC305840|pmid=11080164}}</ref><ref name = pmid11025664>{{Cite journal|last=Guo|first=Ailan|last2=Salomoni|first2=Paolo|last3=Luo|first3=Jianyuan|last4=Shih|first4=Alan|last5=Zhong|first5=Sue|last6=Gu|first6=Wei|last7=Paolo Pandolfi|first7=Pier|date=2000-10|title=The function of PML in p53-dependent apoptosis|url=http://www.nature.com/articles/ncb1000_730|journal=Nature Cell Biology|language=en|volume=2|issue=10|doi=10.1038/35036365|issn=1465-7392|pmid=11025664|access-date=2022-06-16|archive-date=2022-06-16|archive-url=https://web.archive.org/web/20220616080150/https://www.nature.com/articles/ncb1000_730}}</ref>
* [[RPL11|RPL11]],<ref name = pmid15195100>{{Cite journal|last=Bernardi|first=Rosa|last2=Scaglioni|first2=Pier Paolo|last3=Bergmann|first3=Stephan|last4=Horn|first4=Henning F.|last5=Vousden|first5=Karen H.|last6=Pandolfi|first6=Pier Paolo|date=2004-07|title=PML regulates p53 stability by sequestering Mdm2 to the nucleolus|url=http://www.nature.com/articles/ncb1147|journal=Nature Cell Biology|language=en|volume=6|issue=7|doi=10.1038/ncb1147|issn=1465-7392|pmid=15195100|access-date=2022-06-16|archive-date=2022-06-17|archive-url=https://web.archive.org/web/20220617203148/https://www.nature.com/articles/ncb1147}}</ref>
* [[视网膜母细胞瘤蛋白|视网膜母细胞瘤蛋白]]<ref name = pmid9448006>{{Cite journal|last=Alcalay|first=Myriam|last2=Tomassoni|first2=Lucia|last3=Colombo|first3=Emanuela|last4=Stoldt|first4=Stephan|last5=Grignani|first5=Francesco|last6=Fagioli|first6=Marta|last7=Szekely|first7=Laszlo|last8=Helin|first8=Kristian|last9=Pelicci|first9=Pier Giuseppe|date=1998-02|title=The Promyelocytic Leukemia Gene Product (PML) Forms Stable Complexes with the Retinoblastoma Protein|url=https://journals.asm.org/doi/10.1128/MCB.18.2.1084|journal=Molecular and Cellular Biology|language=en|volume=18|issue=2|doi=10.1128/MCB.18.2.1084|issn=0270-7306|pmc=PMC108821|pmid=9448006|access-date=2022-06-16|archive-date=2022-06-16|archive-url=https://web.archive.org/web/20220616063943/https://journals.asm.org/doi/10.1128/MCB.18.2.1084}}</ref>
* [[视黄酸受体α|视黄酸受体α]],<ref name = pmid10610177>{{Cite journal|last=Zhong|first=Sue|last2=Delva|first2=Laurent|last3=Rachez|first3=Christophe|last4=Cenciarelli|first4=Cristina|last5=Gandini|first5=Domenica|last6=Zhang|first6=Hui|last7=Kalantry|first7=Sundeep|last8=Freedman|first8=Leonard P.|last9=Pandolfi|first9=Pier Paolo|date=1999-11|title=A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARα and T18 oncoproteins|url=https://www.nature.com/articles/ng1199_287|journal=Nature Genetics|language=en|volume=23|issue=3|doi=10.1038/15463|issn=1061-4036|pmid=10610177|access-date=2022-06-16|archive-date=2022-03-10|archive-url=https://web.archive.org/web/20220310151122/https://www.nature.com/articles/ng1199_287}}</ref>
* [[SIN3A|SIN3A]],<ref name = pmid11430826/>
* [[SKI_protein|SKI protein]],<ref name = pmid11430826/>
* [[STAT3|STAT3]],<ref name = pmid12506013>{{Cite journal|last=Kawasaki|first=Akira|last2=Matsumura|first2=Itaru|last3=Kataoka|first3=Yoshihisa|last4=Takigawa|first4=Eri|last5=Nakajima|first5=Koichi|last6=Kanakura|first6=Yuzuru|date=2003-05-01|title=Opposing effects of PML and PML/RARα on STAT3 activity|url=https://ashpublications.org/blood/article/101/9/3668/105843/Opposing-effects-of-PML-and-PMLRAR%CE%B1-on-STAT3|journal=Blood|language=en|volume=101|issue=9|doi=10.1182/blood-2002-08-2474|issn=1528-0020|pmid=12506013|access-date=2022-06-16|archive-date=2022-06-16|archive-url=https://web.archive.org/web/20220616064545/https://ashpublications.org/blood/article/101/9/3668/105843/Opposing-effects-of-PML-and-PMLRAR%CE%B1-on-STAT3}}</ref>
* [[Serum_response_factor|Serum response factor]]<ref name = pmid12622724/>and 
* [[Small_ubiquitin-related_modifier_1|Small ubiquitin-related modifier 1]],<ref name = pmid11948183>{{Cite journal|last=Lin|first=Ding-Yen|last2=Shih|first2=Hsiu-Ming|date=2002-07-12|title=Essential role of the 58-kDa microspherule protein in the modulation of Daxx-dependent transcriptional repression as revealed by nucleolar sequestration|url=https://pubmed.ncbi.nlm.nih.gov/11948183|journal=The Journal of Biological Chemistry|volume=277|issue=28|doi=10.1074/jbc.M200633200|issn=0021-9258|pmid=11948183|access-date=2022-06-16|archive-date=2022-06-20|archive-url=https://web.archive.org/web/20220620100617/https://pubmed.ncbi.nlm.nih.gov/11948183/}}</ref><ref name = pmid9452416>{{Cite journal|last=Kamitani|first=T.|last2=Nguyen|first2=H. P.|last3=Kito|first3=K.|last4=Fukuda-Kamitani|first4=T.|last5=Yeh|first5=E. T.|date=1998-02-06|title=Covalent modification of PML by the sentrin family of ubiquitin-like proteins|url=https://pubmed.ncbi.nlm.nih.gov/9452416|journal=The Journal of Biological Chemistry|volume=273|issue=6|doi=10.1074/jbc.273.6.3117|issn=0021-9258|pmid=9452416|access-date=2022-06-16|archive-date=2022-06-20|archive-url=https://web.archive.org/web/20220620223235/https://pubmed.ncbi.nlm.nih.gov/9452416/}}</ref>
* [[Sp1_transcription_factor|Sp1 transcription factor]],<ref name = pmid9819401>{{Cite journal|last=Vallian|first=Sadeq|last2=Chin|first2=Khew-Voon|last3=Chang|first3=Kun-Sang|date=1998-12|title=The Promyelocytic Leukemia Protein Interacts with Sp1 and Inhibits Its Transactivation of the Epidermal Growth Factor Receptor Promoter|url=https://journals.asm.org/doi/10.1128/MCB.18.12.7147|journal=Molecular and Cellular Biology|language=en|volume=18|issue=12|doi=10.1128/MCB.18.12.7147|issn=0270-7306|pmc=PMC109296|pmid=9819401|access-date=2022-06-16|archive-date=2022-06-16|archive-url=https://web.archive.org/web/20220616063925/https://journals.asm.org/doi/10.1128/MCB.18.12.7147}}</ref>
* [[TOPBP1|TOPBP1]],<ref name = pmid12773567>{{Cite journal|last=Xu|first=Zhi-Xiang|last2=Timanova-Atanasova|first2=Anna|last3=Zhao|first3=Rui-Xun|last4=Chang|first4=Kun-Sang|date=2003-06-15|title=PML Colocalizes with and Stabilizes the DNA Damage Response Protein TopBP1|url=https://journals.asm.org/doi/10.1128/MCB.23.12.4247-4256.2003|journal=Molecular and Cellular Biology|language=en|volume=23|issue=12|doi=10.1128/MCB.23.12.4247-4256.2003|issn=0270-7306|pmc=PMC156140|pmid=12773567}}</ref>
* [[Thymine-DNA_glycosylase|Thymine-DNA glycosylase]],<ref name = pmid15569683>{{Cite journal|last=Takahashi|first=Hidehisa|last2=Hatakeyama|first2=Shigetsugu|last3=Saitoh|first3=Hisato|last4=Nakayama|first4=Keiichi I.|date=2005-02-18|title=Noncovalent SUMO-1 binding activity of thymine DNA glycosylase (TDG) is required for its SUMO-1 modification and colocalization with the promyelocytic leukemia protein|url=https://pubmed.ncbi.nlm.nih.gov/15569683|journal=The Journal of Biological Chemistry|volume=280|issue=7|doi=10.1074/jbc.M408130200|issn=0021-9258|pmid=15569683|access-date=2022-06-16|archive-date=2022-06-16|archive-url=https://web.archive.org/web/20220616063922/https://pubmed.ncbi.nlm.nih.gov/15569683/}}</ref>and
* [[Zinc_finger_and_BTB_domain-containing_protein_16|Zinc finger and BTB domain-containing protein 16]].<ref name = pmid9294197>{{Cite journal|last=Koken|first=M. H. M.|last2=Reid|first2=A.|last3=Quignon|first3=F.|last4=Chelbi-Alix|first4=M. K.|last5=Davies|first5=J. M.|last6=Kabarowski|first6=J. H. S.|last7=Zhu|first7=J.|last8=Dong|first8=S.|last9=Chen|first9=S.-J.|last10=Chen|first10=Z.|last11=Tan|first11=C. C.|date=1997-09-16|title=Leukemia-associated retinoic acid receptor α fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies|url=https://pnas.org/doi/full/10.1073/pnas.94.19.10255|journal=Proceedings of the National Academy of Sciences|language=en|volume=94|issue=19|doi=10.1073/pnas.94.19.10255|issn=0027-8424|pmc=PMC23349|pmid=9294197|access-date=2022-06-16|archive-date=2022-06-16|archive-url=https://web.archive.org/web/20220616063941/https://www.pnas.org/doi/full/10.1073/pnas.94.19.10255}}</ref>
{{Div col end}}

== 参见 ==
* [[RING_finger_domain|RING finger domain]]

{{-}}

== 参考文献==
{{reflist|35em}}

== 延伸阅读 ==
{{ReflistH|35em}}
* {{Cite journal|last=Zhong|first=Sue|last2=Salomoni|first2=Paolo|last3=Pandolfi|first3=Pier Paolo|date=2000-05|title=The transcriptional role of PML and the nuclear body|url=http://www.nature.com/articles/ncb0500_E85|journal=Nature Cell Biology|language=en|volume=2|issue=5|doi=10.1038/35010583|issn=1465-7392|pmid=10806494|access-date=2022-06-16|archive-date=2022-03-10|archive-url=https://web.archive.org/web/20220310190550/https://www.nature.com/articles/ncb0500_E85}}
* {{Cite journal|last=Jensen|first=Kirsten|last2=Shiels|first2=Carol|last3=Freemont|first3=Paul S|date=2001-10-29|title=PML protein isoforms and the RBCC/TRIM motif|url=https://www.nature.com/articles/1204765|journal=Oncogene|language=en|volume=20|issue=49|doi=10.1038/sj.onc.1204765|issn=0950-9232|pmid=11704850|access-date=2022-06-16|archive-date=2022-05-25|archive-url=https://web.archive.org/web/20220525134105/https://www.nature.com/articles/1204765}}
* {{Cite journal|last=Pearson|first=Mark|last2=Pelicci|first2=Pier Giuseppe|date=2001-10-29|title=PML interaction with p53 and its role in apoptosis and replicative senescence|url=https://www.nature.com/articles/1204856|journal=Oncogene|language=en|volume=20|issue=49|doi=10.1038/sj.onc.1204856|issn=0950-9232|pmid=11704853|access-date=2022-06-16|archive-date=2022-06-16|archive-url=https://web.archive.org/web/20220616063941/https://www.nature.com/articles/1204856}}>
* {{Cite journal|last=Salomoni|first=Paolo|last2=Pandolfi|first2=Pier Paolo|date=2002-01-25|title=The role of PML in tumor suppression|url=https://pubmed.ncbi.nlm.nih.gov/11832207|journal=Cell|volume=108|issue=2|doi=10.1016/s0092-8674(02)00626-8|issn=0092-8674|pmid=11832207|access-date=2022-06-16|archive-date=2022-03-02|archive-url=https://web.archive.org/web/20220302174938/https://pubmed.ncbi.nlm.nih.gov/11832207/}}
* {{Cite journal|last=Combes|first=Robert|last2=Balls|first2=Michael|last3=Bansil|first3=Lee|last4=Barratt|first4=Martin|last5=Bell|first5=David|last6=Botham|first6=Phil|last7=Broadhead|first7=Caren|last8=Clothier|first8=Richard|last9=George|first9=Elizabeth|last10=Fentem|first10=Julia|last11=Jackson|first11=Michael|date=2002-07|title=An Assessment of Progress in the Use of Alternatives in Toxicity Testing since the Publication of the Report of the Second FRAME Toxicity Committee (1991)|url=http://journals.sagepub.com/doi/10.1177/026119290203000403|journal=Alternatives to Laboratory Animals|language=en|volume=30|issue=4|doi=10.1177/026119290203000403|issn=0261-1929|pmid=12234245|access-date=2022-06-16|archive-date=2021-08-10|archive-url=https://web.archive.org/web/20210810084758/https://journals.sagepub.com/doi/10.1177/026119290203000403}}
* {{Cite journal|last=Bernardi|first=Rosa|last2=Pandolfi|first2=Pier Paolo|date=2003-12-08|title=Role of PML and the PML-nuclear body in the control of programmed cell death|url=https://www.nature.com/articles/1207106|journal=Oncogene|language=en|volume=22|issue=56|doi=10.1038/sj.onc.1207106|issn=0950-9232|pmid=14663483|access-date=2022-06-16|archive-date=2022-06-16|archive-url=https://web.archive.org/web/20220616063922/https://www.nature.com/articles/1207106}}
* {{Cite journal|last=Beez|first=Sabine|last2=Demmer|first2=Philipp|last3=Puccetti|first3=Elena|date=2012-11-09|editor-last=Tse|editor-first=William|title=Targeting the Acute Promyelocytic Leukemia-Associated Fusion Proteins PML/RARα and PLZF/RARα with Interfering Peptides|url=https://dx.plos.org/10.1371/journal.pone.0048636|journal=PLoS ONE|language=en|volume=7|issue=11|doi=10.1371/journal.pone.0048636|issn=1932-6203|pmc=PMC3494703|pmid=23152790}}
{{ReflistF}}

== 外部链接 ==
* {{MeshName|PML+protein,+human}}

{{PDB Gallery|geneid=5371}}